Latest Supply Chains News

Woolworths Group posted solid full-year results for FY26, driven by strong Australian Food sales and complementary businesses, alongside a 15.6% increase in the fully franked final dividend.

Terra Metals has confirmed a substantial extension of its Southwest sulfide discovery at the Dante Project, with new drilling revealing broad, continuous PGM-Cu-Ni mineralisation over a 1,100m strike. Five rigs are drilling aggressively as the company targets a maiden Mineral Resource Estimate by late 2026.

Duratec Limited (ASX:DUR) reported a 4.1% rise in net profit after tax to $23.8 million for FY26 on stable revenue, underpinned by a record $650.8 million order book and multiple strategic acquisitions expanding its service portfolio.

Chalice Mining secures independent endorsement of its Gonneville Project environmental approvals plan, reinforcing its timeline for a Final Investment Decision in the first half of 2028.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

Retail Food Group (ASX:RFG) posted a 10.7% revenue drop to A$127.9 million in FY26 but returned to profit with a statutory net profit of A$1.1 million, driven by cost rationalisation and operational improvements.

PolyNovo reported a 16.1% rise in FY26 revenue to AUD 150 million, driven by strong global sales and manufacturing expansion, yet net profit fell 44% due to a significant asset write-off from an R&D centre fire and lower tax benefits.

Veris Limited lifted revenue by 4.9% to $102 million in FY26, driven by digital and advisory growth, but statutory net profit fell 67% amid one-off costs and macroeconomic headwinds.

Scott Technology aims to more than double Protein Domain revenue to NZ$165 million by FY30, leveraging global growth of its BladeStop safety bandsaw and a new Mexico distribution deal.

Meridian Energy (NZX:MEL) reported a strong turnaround in FY26 with a $130 million net profit after tax, driven by improved hydro and wind generation, retail growth, and strategic investments in renewable projects and grid flexibility.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.